This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsunoda, A. Articles by Koike, T. Search for Related Content PubMed PubMed Citation Articles by Tsunoda, A. Articles by Koike, T.

Reduced Growth Rate of Dimethylhydrazine-induced Colon Tumors in Rats

Department of Surgery, Showa University School of Medicine, 1-5-8 Hatanodai Shinagawa-ku, Tokyo 142, Japan

-Difluoromethylornithine (DFMO) treatment has been shown to modify carcinogenesis in many experimental tumor models, including breast, urinary bladder, and colon. This study was designed to determine whether DFMO treatment can inhibit tumor growth on chemical-induced colon cancer in rats. Effectiveness of DFMO in combination with mitomycin C (MMC) was also evaluated. Forty-two Sprague-Dawley rats received dimethylhydrazine (20 mg/kg) s.c. once weekly for 20 wk to induce colon cancer. Then a double-contrast barium enema was performed, and colon tumors were detected. The animals were divided into four groups that were subjected to the following treatment: none; DFMO alone; MMC alone; and a combination of DFMO plus MMC. After 5 wk of treatment, the barium enema was repeated. For the evaluation of treatment efficacy, tumor doubling time was adopted. The mean tumor doubling time in the control group was 20.7 ± 9.1 days (SD). "Response" was judged as effective when tumor doubling time in treatment groups was more than 38.9 days, calculated from the mean + 2 SDs in the control group. Response rates in the DFMO, MMC, and DFMO plus MMC groups were 40.0%, 10.0%, and 82.3%, respectively. DFMO was a more effective inhibitor of tumor growth than MMC, and DFMO in combination with MMC resulted in a synergic diminution of tumor growth. The double-contrast barium enema is useful to observe sequential tumor growth and may be appropriate for the evaluation of new treatment on experimental colon cancer in rats.

¹ To whom requests for reprints should be addressed.

Received 7/24/91. Accepted 11/12/91.

This article has been cited by other articles:

				A. UMAR, J. L. VINER, and E. T. HAWK The Future of Colon Cancer Prevention Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 88 - 108. [Abstract] [Full Text] [PDF]